Tampa, FL, United States of America

Alejandro V Villagra

USPTO Granted Patents = 11 

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 30(Granted Patents)


Location History:

  • Tampa, FL (US) (2016 - 2021)
  • Falls Church, VA (US) (2022 - 2024)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Alejandro V Villagra: Innovator in Cancer Research

Introduction

Alejandro V Villagra is a prominent inventor based in Tampa, FL (US), known for his significant contributions to cancer research. With a total of 11 patents, he has made remarkable strides in the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic use.

Latest Patents

Among his latest patents, Villagra has focused on isoxazole hydroxamic acids as histone deacetylase 6 inhibitors. The present disclosure provides compounds represented by Formula I and pharmaceutically acceptable salts, solvates, e.g., hydrates, and prodrugs thereof, wherein X and n are as defined in the specification. These compounds are intended for use in treating diseases and conditions, such as cancer, where inhibition of HDAC provides a therapeutic benefit.

Career Highlights

Villagra has had a distinguished career, working at notable institutions such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and the University of Illinois. His work has been instrumental in advancing the understanding and treatment of cancer through innovative research and development.

Collaborations

Throughout his career, Villagra has collaborated with esteemed colleagues, including Eduardo M Sotomayor and Alan P Kozikowski. These partnerships have further enriched his research and contributed to the success of his projects.

Conclusion

Alejandro V Villagra stands out as a key figure in the field of cancer research, with a strong portfolio of patents that reflect his innovative spirit and dedication to improving therapeutic options for patients. His work continues to inspire advancements in medicinal chemistry and cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…